Tata India Pharma & Healthcare Fund details, NAV, Portfolio, Returns, Peer Comparison, Fund Managers & Guidance by sahifund.com
NAV Growth: Rs 36.1435
NAV IDCW: Rs 36.1435
Suitable For Which Investors?
This is a fund that invests mainly in shares of pharmaceutical and healthcare companies.
We believe that investors should avoid funds that have a narrowly defined investment mandate such as this one. Instead, they should invest in flexi-cap funds which provide complete freedom to the fund management team to invest in companies from which it expects maximum gains.
But if you do invest, you must do so only through the SIP route.
Fund’s Investment Strategy:
The scheme seeks long term capital appreciation by investing atleast 80% of it’s net assets in equity/equity related instruments of the companies in the pharma & healthcare sectors in India.
Fund Manager:
1) Rajat Srivastava
Education: Mr. Srivastava has done BBA (Banking & Insurance), PGDM – IMT Ghaziabad
Experience: Prior to joining Tata Mutual Fund, he has worked with Incred Asset Management, Kotak Investment Banking, Emkay Global, Evalueserve and Motilal Oswal Financial Services
Investment Details
Min. Investment (Rs) | 5,000 |
Min. Addl Investment (Rs) | 1,000 |
Min. SIP Investment (Rs) | 100 |
Min. Withdrawal (Rs) | 500 |
Min. No of Cheques | 6 |
Min. Balance (Rs) | 500 |
Lock-in Period | NA |
Exit Load | 0.25% for redemption within 30 days |
Basic Details of Tata India Pharma & Healthcare Fund
Fund House | Tata Mutual Fund |
Launch Date | 28-Dec-15 |
Return Since Launch | 14.14% |
Benchmark | BSE Healthcare TRI |
Riskometer | Very High |
Type | Open-ended |
Assets | Rs 1,309 Cr |
(As on 31-Aug-2025) | |
Expense | 0.62% |
(As on 31-Aug-2025) | |
Risk Grade | Above Average |
Return Grade | Average |
Turnover | 34.23% |
Trailing Returns (%) of Tata India Pharma and Healthcare Fund
Fund name | YTD | 1D | 1M | 3M | 6M | 1Y | 3Y | 5Y | 7Y | 10Y |
Tata India Pharma & Healthcare Dir | -1.36 | 0.05 | 1.20 | 3.82 | 13.77 | 0.02 | 25.34 | 21.21 | 19.95 | — |
BSE Healthcare TRI | -0.27 | 0.27 | 2.54 | 2.52 | 14.50 | 2.00 | 25.30 | 19.71 | 16.71 | — |
Equity: Sectoral-Pharma | -0.24 | 0.18 | 2.16 | 3.31 | 13.79 | 1.08 | 24.57 | 20.35 | 20.27 | — |
Rank within category | 16 | 19 | 20 | 7 | 11 | 11 | 4 | 3 | 3 | — |
Number of funds in category | 21 | 23 | 23 | 21 | 21 | 18 | 11 | 9 | 6 | 3 |
Peer Comparison of Tata India Pharma and Healthcare Fund
Rating | 1 Year Returns | 3 Year Returns | 5 Year Returns | Expense Ratio (%) | Net Assets (Rs Cr) | Return Since Launch (%) | Exit Load (Days) | Fund Age | Turnover (%) | |
Tata India Pharma & Healthcare Dir | 3 star | 0.02 | 25.34 | 21.21 | 0.62 | 1,309 | 14.14 | 0.25 (30) | 9Y 8M | 34.23 |
ICICI Pru Pharma Healthcare and Diagnostics Dir | 4 star | 4.29 | 29.48 | 22.88 | 1.04 | 6,162 | 22.86 | 1.00 (15) | 7Y 2M | 71.00 |
SBI Healthcare Opportunities Dir | 5 star | 4.69 | 27.49 | 22.11 | 0.91 | 3,963 | 18.13 | 0.50 (15) | 12Y 8M | 18.00 |
DSP Healthcare Dir | 4 star | -1.44 | 25.17 | 20.73 | 0.60 | 3,107 | 24.34 | 0.50 (30) | 6Y 9M | 18.00 |
UTI Healthcare Dir | 4 star | 3.31 | 26.89 | 20.51 | 1.30 | 1,118 | 16.57 | 1.00 (30) | 12Y 8M | 29.00 |
Portfolio Analysis of Tata India Pharma & Healthcare Fund
No. of Stocks | 36 |
Top 10 Stocks | 52.89% |
Top 5 Stocks | 31.65% |
Top 3 Sectors | 97.17% |
Portfolio P/B Ratio | 5.81 |
Portfolio P/E Ratio | 42.54 |
Portfolio Breakup
Fund | Category | |
Average Mkt Cap (Rs Cr) | 54,237 | 78,463 |
Giant (%) | 14.35 | 21.20 |
Large (%) | 35.64 | 37.07 |
Mid (%) | 35.73 | 34.76 |
Small (%) | 14.28 | 8.74 |
Tiny (%) | — | 0.05 |
Chanakya’s Mutual Fund Guidance For Tata India Pharma & Healthcare Fund
WILL POST SOON
Disclaimer: Mutual fund investments are subject to market risks. Read all scheme related documents carefully
Apply Online: https://online.tatamutualfund.com/login
>> Post your MF questions @ sahifund.com/ask-me/
>> NFO Guidance:
https://sahifund.com/category/nfos/
Quicklinks
- Chanakyanipothi.com
- Staffavailable.com
- BigGaddi.com
- Latest IPO GMP
- Best Stocks to buy today
- Grey Market Premium
- Upcoming IPOs
- Subscription Status